Xue, J., Li, Y., Yi, J., & Jiang, H. HAVCR1 Affects the MEK/ERK Pathway in Gastric Adenocarcinomas and Influences Tumor Progression and Patient Outcome. Wiley.
Chicago Style (17th ed.) CitationXue, Ji, Ying Li, Jianfeng Yi, and Hong Jiang. HAVCR1 Affects the MEK/ERK Pathway in Gastric Adenocarcinomas and Influences Tumor Progression and Patient Outcome. Wiley.
MLA (9th ed.) CitationXue, Ji, et al. HAVCR1 Affects the MEK/ERK Pathway in Gastric Adenocarcinomas and Influences Tumor Progression and Patient Outcome. Wiley.
Warning: These citations may not always be 100% accurate.